PL1861713T3 - Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworów - Google Patents
Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworówInfo
- Publication number
- PL1861713T3 PL1861713T3 PL06727336T PL06727336T PL1861713T3 PL 1861713 T3 PL1861713 T3 PL 1861713T3 PL 06727336 T PL06727336 T PL 06727336T PL 06727336 T PL06727336 T PL 06727336T PL 1861713 T3 PL1861713 T3 PL 1861713T3
- Authority
- PL
- Poland
- Prior art keywords
- monitoring
- early cancer
- thereapy
- screening
- pet tracers
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 238000012216 screening Methods 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title 1
- 239000000700 radioactive tracer Substances 0.000 abstract 3
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nuclear Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66381805P | 2005-03-21 | 2005-03-21 | |
| US71972605P | 2005-09-22 | 2005-09-22 | |
| US78226106P | 2006-03-14 | 2006-03-14 | |
| EP06727336A EP1861713B1 (en) | 2005-03-21 | 2006-03-20 | Method of screening pet tracers for early cancer thereapy monitoring |
| PCT/IB2006/000621 WO2006100562A2 (en) | 2005-03-21 | 2006-03-20 | Method of screening pet tracers for early cancer thereapy monitoring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1861713T3 true PL1861713T3 (pl) | 2010-03-31 |
Family
ID=36727783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06727336T PL1861713T3 (pl) | 2005-03-21 | 2006-03-20 | Sposób skriningu w kierunku znaczników PET do monitorowania wczesnego leczenia nowotworów |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1861713B1 (pl) |
| AT (1) | ATE443868T1 (pl) |
| CY (1) | CY1109634T1 (pl) |
| DE (1) | DE602006009380D1 (pl) |
| DK (1) | DK1861713T3 (pl) |
| ES (1) | ES2333669T3 (pl) |
| PL (1) | PL1861713T3 (pl) |
| PT (1) | PT1861713E (pl) |
| SI (1) | SI1861713T1 (pl) |
| WO (1) | WO2006100562A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011082191A1 (en) * | 2009-12-30 | 2011-07-07 | Ge Healthcare Limited | Method of using a 99mtc-labelled injection rgd compound and a [18f]-labelled rgd injection compound in external beam radiotherapy planning |
| CA2964367C (en) | 2014-10-14 | 2024-01-30 | Novartis Ag | Antibody molecules to pd-l1 and uses thereof |
| US10633404B2 (en) | 2015-03-10 | 2020-04-28 | Emory University | Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers |
| WO2019106945A1 (ja) * | 2017-11-28 | 2019-06-06 | パナソニックＩｐマネジメント株式会社 | 培養状態判定装置、培養状態判定方法及びプログラム |
| US20240050047A1 (en) * | 2020-12-31 | 2024-02-15 | The Board Of Regents Of The University Of Texas System | Real-time marker-less dynamic tumor tracking |
-
2006
- 2006-03-20 PL PL06727336T patent/PL1861713T3/pl unknown
- 2006-03-20 SI SI200630507T patent/SI1861713T1/sl unknown
- 2006-03-20 AT AT06727336T patent/ATE443868T1/de active
- 2006-03-20 WO PCT/IB2006/000621 patent/WO2006100562A2/en not_active Ceased
- 2006-03-20 PT PT06727336T patent/PT1861713E/pt unknown
- 2006-03-20 DE DE602006009380T patent/DE602006009380D1/de active Active
- 2006-03-20 ES ES06727336T patent/ES2333669T3/es active Active
- 2006-03-20 EP EP06727336A patent/EP1861713B1/en not_active Not-in-force
- 2006-03-20 DK DK06727336T patent/DK1861713T3/da active
-
2009
- 2009-12-11 CY CY20091101300T patent/CY1109634T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1109634T1 (el) | 2014-08-13 |
| EP1861713A2 (en) | 2007-12-05 |
| ES2333669T3 (es) | 2010-02-25 |
| DK1861713T3 (da) | 2010-01-11 |
| DE602006009380D1 (de) | 2009-11-05 |
| WO2006100562A2 (en) | 2006-09-28 |
| PT1861713E (pt) | 2009-12-24 |
| ATE443868T1 (de) | 2009-10-15 |
| EP1861713B1 (en) | 2009-09-23 |
| SI1861713T1 (sl) | 2010-01-29 |
| WO2006100562A3 (en) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201007235D0 (en) | Taz/wwtr1 for diagnosis and treatment of cancer | |
| WO2003068054A3 (en) | Identification of ovarian cancer tumor markers and therapeutic targets | |
| CY1109634T1 (el) | Μεθοδος διαλογης ιχνηλατων pet για εγκαιρη παρακολουθηση της αντικαρκινικης θεραπειας | |
| Mountzios et al. | Developments in the systemic treatment of metastatic cervical cancer | |
| WO2008103645A3 (en) | Prostate cancer and melanoma antigens | |
| MY180365A (en) | Markers of tumor cell response to anti-cancer therapy | |
| EP2598873A4 (en) | BIOMARKERS OF PROSTATE CANCER AND METHODS USING THEM | |
| MX2016012697A (es) | Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. | |
| IL243656B (en) | A system for producing a report that identifies a medical substance for a lung cancer patient | |
| MX2009006779A (es) | Antagonistas especificos para terapia con adyuvantes y neo-adyuvantes y el tratamiento de tumores en etapa temprana. | |
| IL207637A (en) | Choosing a Breast Cancer Remedy Using Antibody-Based Arrays | |
| WO2007081767A3 (en) | Use of he4 and other biochemical markers for assessment of endometrial and uterine cancers | |
| MX2023001945A (es) | Composiciones y metodos para el cribado de tumores solidos. | |
| WO2011086174A3 (en) | Diagnostic gene expression platform | |
| WO2019035100A3 (en) | Prognostic markers for cancer recurrence | |
| MX2010008496A (es) | Metodo para la determinacion de sensibilidad a agente anticancerigeno. | |
| GB2535343A (en) | Formation evaluation using stochastic analysis of log data | |
| WO2007088492A3 (en) | Improved radiation therapy planning procedure | |
| MX2011004979A (es) | N-cadherina:blanco para diagnosis y terapia de cancer. | |
| WO2011146386A3 (en) | Statistically based golf swing analysis kit | |
| WO2011027351A3 (en) | Diagnosis of gastrointestinal cancers through glycome analysis | |
| WO2021007525A3 (en) | Methods and agents for the detection and treatment of cancer | |
| WO2011011453A3 (en) | Phenotyping tumor-infiltrating leukocytes | |
| WO2011051271A3 (en) | Prostate tumor markers and methods of use thereof | |
| MY166248A (en) | Method and device for producing and measuring a borehole |